InvestorWire NewsRoom

Article

DGE’s 2nd Risk-Based Quality Management Summit to Enhance Skills for Successful Risk-Based Monitoring of Clinical Trials
March 25, 2022

DGE’s 2nd Risk-Based Quality Management Summit to Enhance Skills for Successful Risk-Based Monitoring of Clinical Trials

On April 4-5, 2022, biopharma and medical device professionals responsible for clinical operations, data management and risk evaluation are invited to attend the live streaming of the 2nd Risk-Based Quality Management Summit. The event is organized by Dynamic Global Events (“DGE”), an educational conference company specializing in the informational and networking needs of the life science sector.

The 2-day event will start with the chairperson’s opening remarks followed by keynotes on a structured change management program for RBQM success. For successful risk-based monitoring and effective implementation of clinical trials, a world-class end-to-end comprehensive risk management plan is essential. The agenda goes into extensive detail on this topic.

Experts will discuss the effective methods to convince and educate shareholders on the importance of complete buy-in across the organization. They will further talk about the importance of regulatory acceptance of remote monitoring and digital technologies, and also share their expertise on how to comfortably maintain levels of risk tolerance and agility in complex clinical trials while accelerating drug development.

This summit covers new approaches in mitigating risk and managing challenges to clinical trial oversight. The RBQM Summit provides up-to-date strategies on reducing the complexity and costs associated with clinical trials, cutting down the risks involved, and deriving the maximum output from the R&D budget. Companies and professionals will learn how to evaluate risks in virtual trials, understand the complexities involved, and thereafter construct a strong framework for their clinical trials.

Industry leaders with robust experience will share insights on K-97-1 and the FDA’s “Decision Tree”. Attendees will also learn the spotlight benefits of AI and ML for curating unstructured data. They can leverage this platform to explore data literacy as the change agent to deliver study wide insights, and learn to plan and implement QTLs for ICH E6 (“R2”) compliance.

Despite all measures, why do clinical trials fail? Join the valuable sessions at the 2nd Risk-Based Quality Management Summit to understand why studies fail and build strategies to improve trial success.

To learn more, please visit https://ibn.fm/TSqRE

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).